41 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... Penicillium marneffei Infections ... in HIV-AIDS Preventing ... in Severely Ill ... #Treatment #management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease ... Note: Treatment ... clinical manifestation ... #Treatment #management ... opportunistic #infections
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE) Clinical ... Cerebrovascular Disease ... APS), Secondary prevention ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management
Emergency Management of Hyperkalemia in Adults
Assess Patient - Airway Breathing Circulation Disability Exposure (ABCDE) Approach
 •
Emergency Management ... guided by clinical ... Shift K+ into cells ... blood glucose Prevention ... #algorithm #treatment
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... the Management ... 12 000 or <400 cells ... oral antibiotic treatment ... or those with clinical
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
accumulation of clinical ... Assessment • Clinical ... • Autoimmune diseases ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
in HIV-AIDS Preventing ... CMV Disease: ... CMV end-organ disease ... CD4 count >100 cells ... #Treatment #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Immunosuppression • Tumor ... characteristic features Clinical ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
CD4 count <250 cells ... Extrathoracic Disseminated Disease ... • Use until clinical ... Coccidiodomycosis #IDSA #Prevention ... #Treatment #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Immunosuppression • Tumor ... characteristic features Clinical ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB